WO2016149883A1 - Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle - Google Patents

Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle Download PDF

Info

Publication number
WO2016149883A1
WO2016149883A1 PCT/CN2015/074761 CN2015074761W WO2016149883A1 WO 2016149883 A1 WO2016149883 A1 WO 2016149883A1 CN 2015074761 W CN2015074761 W CN 2015074761W WO 2016149883 A1 WO2016149883 A1 WO 2016149883A1
Authority
WO
WIPO (PCT)
Prior art keywords
frequency electromagnetic
electromagnetic wave
water
drinking water
kinetic energy
Prior art date
Application number
PCT/CN2015/074761
Other languages
English (en)
Chinese (zh)
Inventor
王卫星
Original Assignee
欢乐海（北京）水业科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 欢乐海（北京）水业科技有限公司 filed Critical 欢乐海（北京）水业科技有限公司
Priority to AU2015387923A priority Critical patent/AU2015387923A1/en
Priority to PCT/CN2015/074761 priority patent/WO2016149883A1/fr
Publication of WO2016149883A1 publication Critical patent/WO2016149883A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/30—Treatment of water, waste water, or sewage by irradiation
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields

Definitions

  • the invention belongs to the technical field of water treatment, and particularly relates to the use of multi-pole micro-kinetic energy drinking water in preparing beverages, health care products or medicines for lowering blood pressure.
  • Water is an inorganic substance composed of two elements of hydrogen and oxygen, and is a colorless and odorless transparent liquid under normal temperature and normal pressure. Water is one of the most common substances, an important resource for all life, including human beings, and the most important component of living things. Water plays an important role in the evolution of life. Humans have long begun to understand water, and water is regarded as a basic component in the ancient and simple material view of the East and West.
  • the water molecule itself has its special structural shape, it is composed of two hydrogen and one oxygen ion combined at an angle of 104.5. It is an ionization system with an electronic "magnetic polarity". Water molecules exhibit solid crystals below zero and below zero, which we call ice. However, water is not completely liquid at a temperature of from zero to 60 ° C, but exists in the form of a liquid crystal. However, if the temperature is higher than 60 ° C, the liquid crystal molecules will be destroyed.
  • the form of the diluted solute molecules can be contained in its liquid crystals, which is a generally understood dissolution process.
  • the new discovery is that when a solute molecule is separated from a water molecule by some means (eg, through multiple dilutions and oscillations), the water molecule can still maintain a "shape" memory of the solute molecule. When the body cells are exposed to such water molecules, the "shape" memory of the solute molecule is treated as a true solute molecule, which is the cornerstone of homeopathic therapy with more than 200 years of history.
  • Water is composed of two elements of hydrogen and oxygen, but does not exist in nature as a single water molecule. Instead, a group of water molecules (H 2 O) n is present in nature (ie, the above liquid state). Crystallization), the group of water molecules may be chain, ring, agglomerate or grape-like, with at least five water molecules, and more than a dozen, tens to hundreds.
  • Electromagnetic waves have been used to treat water molecules to increase the energy level of water molecules or to disinfect or prevent and remove dirt.
  • these treatment methods do not control the effect of the treatment well, and the effect of the treated water is mostly limited to drinking, and there is no other additional advantageous effect.
  • the present invention provides a multi-pole micro-kinetic energy drinking water obtained by electromagnetic wave non-contact treatment, a preparation method thereof and use thereof.
  • the present invention provides a multi-pole micro-kinetic energy drinking water prepared by non-contact treatment of drinking water raw water by electromagnetic waves, and the ultraviolet absorption peak is short-waved compared with the raw water of drinking water.
  • the direction shift is 25 nm to 40 nm, preferably 28 nm to 30 nm in the short-wave direction, and most preferably 30 nm or 28 nm in the short-wave direction.
  • the spectral intensity of the fluorescent radiation of the multi-pole micro-kinetic energy drinking water of the invention is greatly improved in the spectrum of 300 nm to 400 nm, and repeated experiments on the same sample show that the experiment has good repeatability. .
  • the drinking water raw water is ordinary tap water or various kinds of mineral water or pure water, such as Evian natural mineral water, Cambodia glacier mineral water, Nongfu Spring, Wahaha, and the like.
  • the multi-pole micro-kinetic energy drinking water of the present invention is best consumed or used within 72 hours after preparation.
  • the present invention provides a method for preparing the above-mentioned multi-pole micro-kinetic energy drinking water, which comprises non-contact treatment of drinking water raw water by using electromagnetic waves of low, medium and high frequencies, wherein the frequency of low-frequency electromagnetic waves
  • the range is 30-100 kHz
  • the frequency range of the intermediate frequency electromagnetic wave is 550-720 kHz
  • the frequency range of the high frequency electromagnetic wave is 300-725 MHz.
  • the drinking water raw water is ordinary tap water or various kinds of mineral water or pure water, such as Evian natural mineral water, Cambodia glacier mineral water, Nongfu Spring, Wahaha, and the like.
  • the low frequency electromagnetic wave has a frequency in the range of 45-75 kHz.
  • the intermediate frequency electromagnetic wave has a frequency range of 600-720 kHz.
  • the high frequency electromagnetic wave has a frequency in the range of 300-425 MHz.
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave are a sine wave, a square wave, a sharp wave, a sawtooth wave or a trapezoidal wave.
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave waveform may be the same or different, preferably the same.
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave propagate in the same direction.
  • the high frequency electromagnetic wave is a triangular wave and is perpendicular to a propagation direction of the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave.
  • the low-frequency electromagnetic wave and the high-frequency electromagnetic wave are simultaneously processed by the electromagnetic wave non-contact treatment of the drinking water raw water treatment by using three different frequencies of low, medium and high frequencies, and then the intermediate frequency electromagnetic wave and the high frequency electromagnetic wave are simultaneously processed.
  • the time for simultaneous treatment using the low frequency electromagnetic wave and the high frequency electromagnetic wave is 10-30 minutes, preferably 10-20 minutes; the time for simultaneous treatment using the intermediate frequency electromagnetic wave and the high frequency electromagnetic wave is 10-30 minutes, preferably 10-20 minutes. .
  • the prepared ultraviolet light absorption peak of the multi-pole micro-kinetic energy drinking water is shifted to the short-wave direction by 25 nm to 40 nm, preferably to the short-wave direction by 28 nm to 30 nm, and most preferably to the short-wave direction. 30 nm or 28 nm.
  • the spectral intensity of the fluorescent radiation of the multi-pole micro-kinetic energy drinking water of the invention is greatly improved in the spectrum of 300 nm to 400 nm, and repeated experiments on the same sample show that the experiment has good repeatability. .
  • a method and apparatus for generating electromagnetic waves are conventional techniques in the art.
  • the present invention provides the use of the above-described multi-pole micro-kinetic energy drinking water in the preparation of various mineral water, purified water, beverages, health care products or medicines.
  • the beverage is a functional beverage and can be used for anti-fatigue, weight loss, laxative, blood pressure lowering, blood sugar lowering, blood uric acid and blood urea.
  • the health care product or drug can be used for anti-fatigue, weight loss, laxative, blood pressure lowering, blood sugar lowering, blood uric acid lowering and blood urea lowering.
  • the invention adopts electromagnetic wave non-contact type treatment water, without adding any additives, is simple to manufacture, has high production efficiency and low cost.
  • the multi-pole micro-kinetic energy drinking water of the present invention is more than the drinking water before treatment.
  • the original water produced a significant shift in the ultraviolet absorption peak to the short-wave direction.
  • the spectral intensity of the fluorescent radiation was greatly improved in the 300-400 nm spectrum, and more extranuclear electrons were in the high-energy non-radiative energy level.
  • Animal experiments have proven to have anti-fatigue, weight loss, laxative, blood pressure lowering, blood sugar lowering, blood uric acid and blood urea reduction.
  • FIG 1 shows the effect of water in different treatment groups on peroxide-induced DNA damage
  • FIG. 1 shows the effect of differently treated media on cells
  • 3 is an absorption spectrum distribution of the ordinary drinking water raw water and the multi-pole micro kinetic energy of the present invention obtained by using the ordinary drinking water raw water;
  • Figure 6 is a fluorescence steady state transient test result of ordinary drinking water (raw water) and its multi-pole micro-kinetic energy drinking water;
  • Figure 7 is a fluorescence steady state transient test result of Evian natural mineral water (raw water) and multi-pole micro-kinetic energy drinking water made therewith;
  • Figure 8 shows the fluorescence steady-state transient test results of Vietnamese glacial mineral water (raw water) and multi-pole micro-kinetic energy drinking water made therewith;
  • Figure 9 shows the results of repeatability test of three samples of multi-pole micro-kinetic energy drinking water made from raw water of Georgia glacial mineral water;
  • Figure 10 is a graph showing the effect of multipolar kinetic energy drinking water on blood pressure systolic blood pressure (SBP) in SHR spontaneously hypertensive rats;
  • SBP blood pressure systolic blood pressure
  • Figure 11 is a graph showing the effect of multipolar kinetic energy drinking water on blood pressure diastolic blood pressure (DBP) in SHR spontaneously hypertensive rats;
  • DBP blood pressure diastolic blood pressure
  • Figure 12 is a graph showing the effect of multipolar kinetic energy drinking water on the mean blood pressure (MBP) of SHR spontaneously hypertensive rats;
  • Figure 13 is a graph showing the effect of multi-polar micro-kinetic energy drinking water on heart rate (HR) in SHR spontaneously hypertensive rats;
  • Figure 14 is a graph showing the effect of multi-polar micro-kinetic energy drinking water on the body weight of SHR spontaneously hypertensive rats ring;
  • electromagnetic waves of three different frequencies of low, medium and high are applied in a non-contact manner, wherein the frequency of the low frequency electromagnetic wave is 30 kHz, the frequency range of the intermediate frequency electromagnetic wave is 550 kHz, and the frequency range of the high frequency electromagnetic wave is 300 MHz. .
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave are both sinusoidal waves, and the electromagnetic wave propagation directions of the two are the same.
  • the high frequency electromagnetic wave is a triangular wave and is perpendicular to a propagation direction of the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave.
  • non-contact electromagnetic waves of low, medium and high frequencies are applied, wherein the frequency of the low frequency electromagnetic waves is 100 kHz, the frequency range of the intermediate frequency electromagnetic waves is 720 kHz, and the frequency range of the high frequency electromagnetic waves is 725 MHz. .
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave are both square waves, and the electromagnetic wave propagation directions of the two are the same.
  • the high frequency electromagnetic wave is a triangular wave and is perpendicular to a propagation direction of the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave.
  • electromagnetic waves of low, medium and high frequencies are applied non-contactly, wherein the frequency of the low frequency electromagnetic waves is 45 kHz, the frequency range of the intermediate frequency electromagnetic waves is 600 kHz, and the frequency range of the high frequency electromagnetic waves is 300 MHz. .
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave are both square waves, and the electromagnetic wave propagation directions of the two are the same.
  • the high frequency electromagnetic wave is a triangular wave and is perpendicular to a propagation direction of the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave.
  • non-contact electromagnetic waves of low, medium and high frequencies are applied, wherein the frequency of the low frequency electromagnetic waves is 75 kHz, the frequency range of the intermediate frequency electromagnetic waves is 720 kHz, and the frequency range of the high frequency electromagnetic waves is 425 MHz. .
  • the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave are sharp waves, and the electromagnetic wave propagation directions of the two are the same.
  • the high frequency electromagnetic wave is a triangular wave and is perpendicular to a propagation direction of the low frequency electromagnetic wave and the intermediate frequency electromagnetic wave.
  • the multi-pole micro-kinetic energy drinking water prepared in Examples 1-4 was tested according to the Standard Test Method for Drinking Water (GB/T 5750-2006), and the test results were basically the same. The results are shown in Table 1.
  • the indicators of the micro-kinetic energy drinking water of the present invention all meet the requirements of the Sanitary Standard for Drinking Water (GB5749-2006).
  • Test substance Micro-kinetic energy drinking water prepared in Example 3
  • Animals Kunming species of white mice were provided by the Laboratory Animal Resources Research Institute of China Food and Drug Control Research Institute (Qualification No.: SCXK (Beijing) 2009-0017), SPF Grade, body weight 18.0 ⁇ 22.0g, before the test, the animals fasted overnight, free to drink water.
  • Dose grouping The test substance was set at a dose of 20000 mg/kg body weight, and 10 female and male animals. Grouped by sex. The dose was calculated by oral gavage at 0.1 ml/10 g body weight.
  • the oral LD 50 of the test article for both female and male mice is greater than 10000 mg/kg body weight, which is an actual non-toxic grade.
  • Plasmid DNA pET28a plasmid was amplified and extracted in DH5a E. coli (plasmid extraction kit was purchased from Promega);
  • EDTA is provided by Sinopharm Chemical Reagent Co., Ltd.;
  • Electrophoresis instrument Liuyi Instrument Factory
  • Test substance Micro-kinetic energy drinking water prepared in Examples 3 and 4
  • Group I untreated group, adding untreated sterile water to the reaction system;
  • Group II the kinetic energy drinking water prepared in Example 3;
  • Group III The kinetic energy drinking water prepared in Example 4.
  • reaction materials were added in the following order, and the final volume of the reaction system was 10 ⁇ L:
  • reaction was stopped by adding 1 ⁇ L of 5 mM EDTA and 2.2 ⁇ L of loading buffer at 0.5 hour and 1 hour, respectively.
  • the redox reaction between vitamin C and divalent copper ions is accompanied by the formation of peroxide, which causes damage to the plasmid DNA, which is reflected in the weakening of the electrophoresis band.
  • the results of this experiment are shown in Figure 1.
  • the experiments were divided into three groups. The grouping method is described in the scheme. The two time points of each group were: 0.5 hours and 1 hour, and the brightness of DNA represented the DNA content.
  • the rate of degradation of plasmid DNA by redox reaction was basically the same in group II and group III compared with untreated group I, and there was no effect of preventing or accelerating DNA damage and cleavage due to water treatment.
  • Vitamin C undergoes redox reaction with divalent copper ions, accompanied by peroxide formation. Peroxide can cause damage to the plasmid DNA, which is reflected in the weakening of the electrophoresis band.
  • the results of this experiment showed that the rate of degradation of plasmid DNA by redox reaction was basically the same in group II and group III compared with untreated group I, and there was no industrial effect of preventing or accelerating DNA damage and cleavage due to water treatment. It is indicated that the multipolar micro kinetic energy of the present invention has no effect on peroxide-induced DNA damage.
  • FAM-aptamer purchased from Shanghai Shenggong Bioengineering Co., Ltd.;
  • the cell culture medium adherently cultured in a 96-well plate was changed to medium A and medium B containing FAM-C6-8 aptamer, cultured at 37 ° C for 30 min, washed once with PBS, and observed under a fluorescence microscope.
  • Fig. 2 There is no difference in cell morphology between the treated group and the untreated group.
  • the cells are white-fluorescent, the cell membrane is intact, and no obvious FAM-labeled C6-8aptamer green fluorescence is observed in the cells.
  • the FAM-labeled C6-8 aptamer can enter the cell and bind to the protein inside the cell, and emit green fluorescence after excitation at 530 wavelength. And the results in the figure see the processing group There is no difference between the cells in the untreated group and the cells, which are autofluorescence, indicating that the cell membrane is intact.
  • the multipolar microkinetic energy technology of the present invention has no effect on cell morphology and cell membrane integrity.
  • Glacier Mineral Water Purchased at Carrefour Supermarket
  • Ultrapure water made by the German Sartorius ultrapure water preparation system
  • Example 3 The ordinary drinking water raw water used in Example 3 and the micro-kinetic energy drinking water prepared in Example 3 were placed in an experimental vessel, and the absorption of the spectral light spectrum of the standard light source of the sample of 200 nm to 800 nm was scanned, and the experimental results were recorded.
  • Example 3 The micro-kinetic energy prepared in Example 3 is placed in an ultraviolet intensity detecting system, the ultraviolet light source illuminates the water to be tested, and the photodetector Thorlab DET10A/M is read by an oscilloscope MS04104 to read ultraviolet rays that have not passed the water to be tested.
  • the intensity value is read by the value of the ultraviolet intensity of the water to be tested, continuously tested continuously for 72 hours, and the amount of change in ultraviolet intensity during the recording.
  • Example 3 The drinking water made from the Vietnamese glacial mineral water in the same manner as in Example 3 is placed in the ultraviolet intensity detecting system, and the step (2) is repeated to record the amount of change in the ultraviolet intensity during the recording.
  • Multi-pole micro-kinetic energy drinking water made from ordinary water
  • Multi-pole micro-kinetic energy drinking water made from Evian natural mineral water
  • Multi-pole micro-kinetic energy drinking water made from Vietnamese glacial mineral water
  • the absorption spectrum absorption peak of the multi-pole micro-kinetic energy drinking water of the present invention is shifted to a short wave by about 30 nm;
  • Glacier Mineral Water Purchased at Carrefour Supermarket
  • Ultrapure water made by the German Sartorius ultrapure water preparation system
  • Test environment temperature 22 ° C, humidity 37%.
  • Example 3 The micro-kinetic energy prepared in Example 3 is placed in a sample cell of a fiber optic spectrometer, and an excitation pulse is given to the sample by a 266 nm pulsed ultraviolet laser, and the spectral spectrum of the sample is used to measure the emission spectrum of the sample. Fluorescence emission spectrum of the sample.
  • Example 3 The ordinary drinking water raw water used in Example 3 was placed in the fiber optic spectrometer sample cell, and step 2 was repeated to record the experimental data.
  • the fluorescence steady-state transient test results of ordinary drinking water and multi-pole micro-kinetic drinking water made by it are shown in Fig. 6.
  • the fluorescence steady-state transient test results of Evian natural mineral water and its multi-pole micro-kinetic drinking water are shown in Figure 7.
  • the fluorescence steady-state transient test results of Vietnamese glacial mineral water and multi-pole micro-kinetic drinking water made by it are shown in Fig. 8.
  • the glacial mineral water in Moscow was tested for repeatability by taking three samples of multi-polar micro-kinetic energy drinking water made of raw water. The results are shown in Figure 9.
  • the multi-pole micro-kinetic energy drinking water (kinetic energy water) prepared in Example 3 is a colorless and odorless transparent aqueous liquid, which is stored at room temperature and used within 72 hours after preparation;
  • the positive drug amlodipine besylate was produced by Guangdong Pi Di Pharmaceutical Co., Ltd., batch number 20140401.
  • Feeding conditions Experimental animal facilities continue to maintain barrier environmental standards.
  • the control range of the main environmental indicators room temperature 20 ⁇ 26 ° C, the daily temperature difference ⁇ 4 ° C.
  • the relative humidity is 40 to 70%.
  • Minimum air exchange times 15 times / hour, light illumination: dark 12h: 12h.
  • the animals are housed in a polypropylene rat group box.
  • the cage specifications are: 545*395*200mm 3 , 5 per box, and the feeding space meets the minimum space required for experimental animals in the national standard GB14925-2010 of the People's Republic of China. Provisions. All animals are managed by trained personnel. Replace the litter and cage once a week. Rat-specific feed is added daily for animal consumption, and the animal's diet is kept free during the whole feeding process.
  • Baoding appliances should be of reasonable structure, appropriate specifications, sturdy and durable, environmentally friendly and easy to operate. The mandatory restrictions on the animal's body should be reduced to a minimum without affecting the experiment.
  • Sample collection The operation of collecting samples for experimental animals in a safe and humane manner (minimizing the tension and discomfort caused to animals).
  • Test indicators animal general observation, weight, growth status, blood pressure, heart rate.
  • the daily dose of adult is 10mg
  • the human body weight is calculated according to 60kg, which is 0.167mg/kg, 2mg/kg is about 12 times of human dose, prepared with 0.5% CMC-Na); kinetic energy plus amlodipine besylate group
  • the dose of amlodipine besylate was also 2 mg/kg, which was prepared with kinetic energy.
  • the weight results were processed using SPSS statistical software and compared between the drug-administered group and the control group. According to the following method: Kolmogorov-Smirnov method should be used for normal test, Levene median method for homogeneity test of variance, if P>0.05, one-way ANOVA method, if normal and variance The homogeneity test failed (P ⁇ 0.05), then a non-parametric Mann-Whitney test was required.
  • the heart rate of the animal has no effect, and it can be judged that the kinetic energy has the function of assisting blood pressure lowering; if the blood pressure of the amlodipine besylate group is lower than that of the amlodipine besylate group, it can be determined that the kinetic energy has enhanced benzene sulfonate The role of the level of blood pressure lowering effect.
  • the systolic blood pressure of the low-activity and high-dose groups returned to the control group, no statistical difference; amlodipine 2 mg/kg group, amlodipine besylate 2 mg/ The systolic blood pressure of the kg-energy water group also returned to the control level.
  • DBP diastolic blood pressure
  • the amlodipine 2 mg/kg group After continuous administration for 15 days, compared with the control group, the low- and high-dose kinetic energy group, the amlodipine 2 mg/kg group, the amlodipine besylate 2 mg/kg plus the kinetic energy group had a certain degree of diastolic blood pressure reduction. However, the magnitude of the change was not large, and no statistical difference was found (p>0.05).
  • the diastolic blood pressure of the kinetic energy low group decreased to a certain extent, the decrease was 11.2%, but no statistical difference was found.
  • amlodipine The diastolic blood pressure of the 2 mg/kg group and the amlodipine besylate 2 mg/kg group were significantly decreased (135 ⁇ 23, 148 ⁇ 9, 111 ⁇ 24**, 99 ⁇ 14**, vs 152 ⁇ 10, mmHg, **p ⁇ 0.01).
  • the diastolic blood pressure of the low-activity and high-dose groups returned to the control group, no statistical difference; amlodipine 2 mg/kg group, amlodipine besylate 2 mg/ The systolic blood pressure of the kg-energy water group also returned to the control level.
  • the mean pressure of the kinetic energy low and high dose groups returned to the control group, no statistical difference; amlodipine 2 mg/kg group, amlodipine besylate 2 mg
  • the systolic blood pressure of the /kg plus energy group also returned to the level of the control group.
  • the mean pressure of the amlodipine besylate 2mg/kg plus kinetic energy group increased compared with the control group, with statistical difference (174 ⁇ 13*, vs 161 ⁇ 13, mmHg, *p ⁇ 0.05), it is concluded that this phenomenon is related to the continuous blood pressure reduction, and the physiological rebound of blood pressure after stopping the drug.
  • the heart rate of the low-dose kinetic energy group and the amlodipine besylate 2 mg/kg plus kinetic energy group was not statistically different from the control group.
  • the high-dose group of kinetic energy and benzenesulfonate The heart rate of the amlodipine 2 mg/kg group increased, with statistical difference (438 ⁇ 60*, 439 ⁇ 44**, vs 361 ⁇ 67, times/min, *p ⁇ 0.05, **p ⁇ 0.01).
  • kinetic energy was continuously administered for 15 days and administered for 36 days. Compared with the control group, the kinetic energy was low, the high dose group, the amlodipine 2 mg/kg group, and the amlodipine besylate 2 mg/ The weight of the kinetic energy of the kg-energy water group is relatively uniform.
  • Example 10 Effect of multi-polar micro-kinetic energy drinking water of the present invention on blood pressure of normal SD rats
  • the multi-pole micro-kinetic energy drinking water (kinetic energy water) prepared in Example 3 is a colorless and odorless transparent aqueous liquid, which is stored at room temperature and used within 72 hours after preparation;
  • the positive drug hypotension pill was produced by Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory, batch number 12072918.
  • Feeding conditions Experimental animal facilities continue to maintain barrier environmental standards.
  • the control range of the main environmental indicators room temperature 20 ⁇ 26 ° C, the daily temperature difference ⁇ 4 ° C.
  • the relative humidity is 40 to 70%.
  • Minimum air exchange times 15 times / hour, light illumination: dark 12h: 12h.
  • the animals are housed in a polypropylene rat group box.
  • the cage specifications are: 545*395*200mm 3 , 5 per box, and the feeding space meets the minimum space required for experimental animals in the national standard GB14925-2010 of the People's Republic of China. Provisions. All animals are managed by trained personnel. Replace the litter and cage once a week. Rat-specific feed is added daily for animal consumption, and the animal's diet is kept free during the whole feeding process.
  • Baoding appliances should be of reasonable structure, appropriate specifications, sturdy and durable, environmentally friendly and easy to operate. The mandatory restrictions on the animal's body should be reduced to a minimum without affecting the experiment.
  • Sample collection The operation of collecting samples for experimental animals in a safe and humane manner (minimizing the tension and discomfort caused to animals).
  • Test indicators animal general observation, weight, growth status, blood pressure, heart rate.
  • Blood pressure measurement the first week of administration (day 4 of administration), the second week of administration (day 11 of administration), the third week of administration (day 18 of administration), and the fourth week of administration (administration) Day 25)
  • Body weight measurement pre-drug, first week of administration (day 8 of administration), second week of administration (day 15 of administration), third week of administration (day 22 of administration), fourth week of administration (Day 29 of administration)
  • the weight results were processed using SPSS statistical software and compared between the drug-administered group and the control group. According to the following method: Kolmogorov-Smirnov method should be used for normal test, Levene median method for homogeneity test of variance, if P>0.05, one-way ANOVA method, if normal and variance The homogeneity test failed (P ⁇ 0.05), then a non-parametric Mann-Whitney test was required.
  • the blood pressure of the experimental group was significantly lower than that of the control group, the difference was significant, and there was no effect on the heart rate of the experimental group, and the experimental results of the auxiliary blood pressure lowering functional animals were determined to be positive.
  • the first week, the second week, the third week, and the fourth week of administration compared with the control group, the systolic blood pressure of the rats with low kinetic energy and high dose group was not statistically compared with the control group. Learning differences, the absolute value did not change much (p>0.05). Compared with the control group, there was no statistical difference in systolic blood pressure between the rats in the antihypertensive group, and the absolute value of the absolute value did not change much (p>0.05).
  • the diastolic blood pressure of the rats with low kinetic energy and high dose group was not statistically compared with the control group. Learning differences, the absolute value did not change much (p>0.05). Compared with the control group, there was no statistical difference in diastolic blood pressure between the rats in the antihypertensive group, and the absolute value of the absolute value did not change much (p>0.05).
  • the third week and the fourth week of administration compared with the control group, the body weight of the low dose group of kinetic energy increased, which was statistically different from the control group (third week: 254 ⁇ 9*, vs 241 ⁇ 14; fourth week: 269 ⁇ 6**, vs 252 ⁇ 17, g, *p ⁇ 0.05, **p ⁇ 0.01).

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hydrology & Water Resources (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des utilisations d'une eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle. Ladite eau potable microcinétique multipolaire est préparée à partir d'une eau potable brute qui est passée à travers une onde électromagnétique sans contact. Par comparaison avec l'eau potable brute, le pic d'absorption dans l'ultraviolet est décalé de 25 nm à 40 nm dans la direction des ondes courtes, le décalage préféré étant de 28 nm à 30 nm dans la direction des ondes courtes, et le décalage optimal étant soit de 30 nm, soit de 28 nm dans la direction des ondes courtes.
PCT/CN2015/074761 2015-03-20 2015-03-20 Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle WO2016149883A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2015387923A AU2015387923A1 (en) 2015-03-20 2015-03-20 Uses of multipolar microkinetic drinking water in preparing drink, healthcare or medicament used for reducing blood pressure
PCT/CN2015/074761 WO2016149883A1 (fr) 2015-03-20 2015-03-20 Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/074761 WO2016149883A1 (fr) 2015-03-20 2015-03-20 Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle

Publications (1)

Publication Number Publication Date
WO2016149883A1 true WO2016149883A1 (fr) 2016-09-29

Family

ID=56976993

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/074761 WO2016149883A1 (fr) 2015-03-20 2015-03-20 Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle

Country Status (2)

Country Link
AU (1) AU2015387923A1 (fr)
WO (1) WO2016149883A1 (fr)

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02131186A (ja) * 1988-11-10 1990-05-18 Fuji Keiki:Kk 簡易型水処理装置
CN1173997A (zh) * 1997-08-20 1998-02-25 郑州粮食学院 一种能产生生物效应的电磁场方法及其设备
CN2635659Y (zh) * 2003-07-03 2004-08-25 马士科技有限公司 应用电磁波对水进行特定处理的设备
CN2778796Y (zh) * 2004-06-04 2006-05-10 赵政坤 磁化活化饮水机
CN101046686A (zh) * 2007-03-21 2007-10-03 王广生 智能化水处理装置
KR20080083789A (ko) * 2007-03-13 2008-09-19 서희동 소집단수제조장치
CN101466643A (zh) * 2006-05-29 2009-06-24 株式会社志贺机能水研究所 水的电磁场处理方法及电磁场处理装置
CN201722187U (zh) * 2010-03-12 2011-01-26 郑士丰 创生水器结构
CN103058430A (zh) * 2012-12-18 2013-04-24 华南理工大学 一种高能小分子水的制备方法
CN202924802U (zh) * 2012-12-03 2013-05-08 周绮玲 一种用于管道内水处理的杀菌灭藻装置及水循环系统
CN104720058A (zh) * 2015-03-20 2015-06-24 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于通便的饮料、保健品或药物中的用途
CN104757675A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血尿酸的饮料、保健品或药物中的用途
CN104757672A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于减肥的饮料、保健品或药物中的用途
CN104757674A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于抗疲劳的饮料、保健品或药物中的用途
CN104757673A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血压的饮料、保健品或药物中的用途
CN104784207A (zh) * 2015-03-20 2015-07-22 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血尿素的饮料、保健品或药物中的用途
CN104803440A (zh) * 2015-03-20 2015-07-29 欢乐海（北京）水业科技有限公司 一种多极微动能饮用水及其制备方法和用途

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02131186A (ja) * 1988-11-10 1990-05-18 Fuji Keiki:Kk 簡易型水処理装置
CN1173997A (zh) * 1997-08-20 1998-02-25 郑州粮食学院 一种能产生生物效应的电磁场方法及其设备
CN2635659Y (zh) * 2003-07-03 2004-08-25 马士科技有限公司 应用电磁波对水进行特定处理的设备
CN2778796Y (zh) * 2004-06-04 2006-05-10 赵政坤 磁化活化饮水机
CN101466643A (zh) * 2006-05-29 2009-06-24 株式会社志贺机能水研究所 水的电磁场处理方法及电磁场处理装置
KR20080083789A (ko) * 2007-03-13 2008-09-19 서희동 소집단수제조장치
CN101046686A (zh) * 2007-03-21 2007-10-03 王广生 智能化水处理装置
CN201722187U (zh) * 2010-03-12 2011-01-26 郑士丰 创生水器结构
CN202924802U (zh) * 2012-12-03 2013-05-08 周绮玲 一种用于管道内水处理的杀菌灭藻装置及水循环系统
CN103058430A (zh) * 2012-12-18 2013-04-24 华南理工大学 一种高能小分子水的制备方法
CN104720058A (zh) * 2015-03-20 2015-06-24 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于通便的饮料、保健品或药物中的用途
CN104757675A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血尿酸的饮料、保健品或药物中的用途
CN104757672A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于减肥的饮料、保健品或药物中的用途
CN104757674A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于抗疲劳的饮料、保健品或药物中的用途
CN104757673A (zh) * 2015-03-20 2015-07-08 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血压的饮料、保健品或药物中的用途
CN104784207A (zh) * 2015-03-20 2015-07-22 欢乐海（北京）水业科技有限公司 多极微动能饮用水在制备用于降血尿素的饮料、保健品或药物中的用途
CN104803440A (zh) * 2015-03-20 2015-07-29 欢乐海（北京）水业科技有限公司 一种多极微动能饮用水及其制备方法和用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG, JIANPING ET AL.: "Structural Change of Water Clusters and the Corresponding Biological Effects", CHEMISTRY, vol. 67, no. 04, 18 April 2004 (2004-04-18), ISSN: 0441-3776 *

Also Published As

Publication number Publication date
AU2015387923A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
Zhang et al. Dietary iron oxide nanoparticles delay aging and ameliorate neurodegeneration in drosophila
Jiang et al. Sodium hydrosulfide attenuates cerebral ischemia/reperfusion injury by suppressing overactivated autophagy in rats
Grespan et al. Anti-arthritic effect of eugenol on collagen-induced arthritis experimental model
Gutowska et al. Fluoride as a pro-inflammatory factor and inhibitor of ATP bioavailability in differentiated human THP1 monocytic cells
Zhou et al. Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1‐dependent mitochondrial fission
Ye et al. Calcium influx blocked by SK&F 96365 modulates the LPS plus IFN-γ-induced inflammatory response in murine peritoneal macrophages
Dan et al. Evaluation of hydroxyapatite nanoparticles-induced in vivo toxicity in Drosophila melanogaster
Zhang et al. Near‐infrared‐enpowered nanomotor‐mediated targeted chemotherapy and mitochondrial phototherapy to boost systematic antitumor immunity
CN104803440B (zh) 一种多极微动能饮用水及其制备方法和用途
Chen et al. Hydrogenated germanene nanosheets as an antioxidative defense agent for acute kidney injury treatment
CN104784207A (zh) 多极微动能饮用水在制备用于降血尿素的饮料、保健品或药物中的用途
Asadpour et al. Effect of zirconium dioxide nanoparticles on glutathione peroxidase enzyme in PC12 and N2a cell lines
CN104757673A (zh) 多极微动能饮用水在制备用于降血压的饮料、保健品或药物中的用途
CN104757675A (zh) 多极微动能饮用水在制备用于降血尿酸的饮料、保健品或药物中的用途
CN104720058A (zh) 多极微动能饮用水在制备用于通便的饮料、保健品或药物中的用途
CN104757672A (zh) 多极微动能饮用水在制备用于减肥的饮料、保健品或药物中的用途
CN104757674A (zh) 多极微动能饮用水在制备用于抗疲劳的饮料、保健品或药物中的用途
Šadzevičienė et al. Inhibition of peripheral blood neutrophil oxidative burst in periodontitis patients with a homeopathic medication Traumeel S
WO2016149883A1 (fr) Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de soins de santé ou de médicaments utilisés pour réduire la pression artérielle
WO2016149886A1 (fr) Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de produits de santé ou de médicaments destinés à être utilisés pour réduire le taux d'urée dans le sang
WO2016149885A1 (fr) Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de produits de santé ou de médicaments permettant de réduire le taux d'urée dans le sang
RU2530639C1 (ru) Способ профилактики вредных эффектов общетоксического и генотоксического действия наносеребра на организм
WO2016149879A1 (fr) Utilisations d'eau potable microcinétique multipolaire dans la préparation de boisson, de produit de soins de santé ou de médicament utilisé pour lutter contre la fatigue
WO2016149872A1 (fr) Eau potable microcinétique multipolaire, son procédé de préparation et ses utilisations
WO2016149876A1 (fr) Utilisations d'eau potable microcinétique multipolaire dans la préparation de boissons, de produits de santé ou de médicaments utilisés pour la perte de poids

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15885822

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2015387923

Country of ref document: AU

Date of ref document: 20150320

Kind code of ref document: A

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 16/01/2018)

122 Ep: pct application non-entry in european phase

Ref document number: 15885822

Country of ref document: EP

Kind code of ref document: A1